Cargando…
miR-26a inhibits atherosclerosis progression by targeting TRPC3
BACKGROUND: Atherosclerosis, a chronic multi-factorial vascular disease, has become a predominant cause of a variety of cardiovascular disorders. miR-26a was previously reported to be involved in atherosclerosis progression. However, the underlying mechanism of miR-26a in atherosclerosis remains to...
Autores principales: | Feng, Min, Xu, Daqian, Wang, Lirui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775568/ https://www.ncbi.nlm.nih.gov/pubmed/29387339 http://dx.doi.org/10.1186/s13578-018-0203-9 |
Ejemplares similares
-
MiR-193-3p inhibits the malignant progression of atherosclerosis by targeting WDR5
por: Yang, Kai, et al.
Publicado: (2022) -
lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
por: Liu, Yan, et al.
Publicado: (2020) -
miR-199a Is Upregulated in GDM Targeting the MeCP2-Trpc3 Pathway
por: Guan, Chun-Yi, et al.
Publicado: (2022) -
MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020) -
MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis
por: Zhang, Yong, et al.
Publicado: (2015)